Absence of Molnupiravir sales to impact year-on-year performance.
Source link
Q1FY24 Preview: Divi’s Laboratories: Revenue seen at Rs. 20,470 million, PAT at Rs. 4,378 million
Date:
More like thisRelated
11 of the best gluten-free breads, tried and tested
<img src="https://images.immediate.co.uk/production/volatile/sites/30/2022/05/Reviews-background-5-c514477.jpg?quality=45&resize=620,413" srcset="https://images.immediate.co.uk/production/volatile/sites/30/2022/05/Reviews-background-5-c514477.jpg?quality=45&resize=2400,1598 2400w, https://images.immediate.co.uk/production/volatile/sites/30/2022/05/Reviews-background-5-c514477.jpg?quality=45&resize=1920,1278 1920w, https://images.immediate.co.uk/production/volatile/sites/30/2022/05/Reviews-background-5-c514477.jpg?quality=45&resize=1440,959 1440w,...
Rupert Murdoch steps down as Fox and News Corp chairman in favour of son Lachlan
The media mogul says he is stepping down...
World News in Brief: Peace day, high seas treaty, Palestinian displacement rises, polio in Ukraine
“People and our planet are in crisis”, the...